Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Period:
Draw Mode:
| Volume | 2,077,611 |
|
|||||
| News | - | ||||||
| Day High | 12.87 | Low High |
|||||
| Day Low | 12.31 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Iovance Biotherapeutics Inc | IOVA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.29 | 2.32% | 12.79 | 13:30:07 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.87 | 12.31 | 12.87 | 12.50 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17,684 | 2,077,611 | $ 12.55 | $ 26,068,357 | - | 3.21 - 18.33 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:30:07 | 100 | $ 12.79 | USD |
Iovance Biotherapeutics (IOVA) Options Flow Summary
Iovance Biotherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.56B | 279.31M | - | 1.19M | -444.04M | -1.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Iovance Biotherapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IOVA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 11.50 | 12.9974 | 11.16 | 11.98 | 4,125,992 | 1.29 | 11.22% |
| 1 Month | 14.08 | 14.21 | 11.01 | 12.25 | 4,199,800 | -1.29 | -9.16% |
| 3 Months | 8.08 | 18.33 | 7.96 | 14.06 | 9,204,694 | 4.71 | 58.29% |
| 6 Months | 3.92 | 18.33 | 3.76 | 10.65 | 8,330,605 | 8.87 | 226.28% |
| 1 Year | 6.37 | 18.33 | 3.21 | 8.87 | 7,184,830 | 6.42 | 100.78% |
| 3 Years | 31.88 | 32.10 | 3.21 | 10.63 | 4,473,086 | -19.09 | -59.88% |
| 5 Years | 11.16 | 54.2081 | 3.21 | 14.32 | 3,324,006 | 1.63 | 14.61% |
Iovance Biotherapeutics Description
| Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company. The company focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient's immune system to eradicate cancer cells. Its lead pipeline candidate, LN-145, is an adoptive cell therapy using tumor-infiltrating lymphocytes to treat patients with refractory metastatic melanoma. |
